• Identify pharmaceutical products (PPs) which might affect human fecundity.
  
  
• Identify the mechanism(s) involved in their fecundity disrupting activity.
  
  
• Develop diagnostic methods and high throughput screening assays (HTSAs) for monitoring PPs.
  
  
• Evaluate environmental, food and population exposure to high risk PPs.
  
  
• Assess possible links between food and fecundity.
  
  
• Establish strategies for risk management.
  
  
• Disseminate the knowledge.
  
  

project brochure